http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad6b0fb8d611f06d27c5cccbfba298ec
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Belardinelli |
| name | Luiz Belardinelli |
| given-name | Luiz |
| organization-name | Gilead Palo Alto Incorporated, Palo Alto, California; and Department of Biology Cardiovascular Therapeutic Area Gilead Sciences Foster City CA USA Gilead Sciences Incorporated, Palo Alto, California From the Departments of Anesthesiology (A.E.M., T.E.M., D.M.D.), Medicine (L.B.), and Pharmacology (L.B., D.M.D.), University of Florida, Gainesville. Department of Biology, Gilead Science, Foster City, CA (L.B., S.R.). From Masonic Medical Research Laboratory (J.M.D., C.A.), Utica, NY, and CV Therapeutics, Inc (L.B.), Palo Alto, Calif. >From the Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy (I.O., B.T., A.F.); Vita Salute University and Scientific Institute San Raffaele, Milan, Italy (P.G.C.); Dipartimento Cardiotoracovascolare, Ospedale Niguarda, Milan, Italy (P.A.M.); Ospedale S. Orsola Malpighi, Bologna, Italy (C.R.); Clinic of General and Interventional Cardiology, University Heart Center, Hamburg, Germany (M.P.); Cardiology Department, Hospital General Universitario de Alicante, ISABIAL - FISABIO,... From the Masonic Medical Research Laboratory, Utica, NY (S.S., J.B., C.A.); and Gilead Sciences, Inc, Foster City, CA (L.B.). Gilead Sciences, Inc. Foster City CA USA Department of Biology, Gilead Sciences Fremont CA USA Department of Pharmacology & Therapeutics, University of Florida College of Medicine , Gainesville; Department of Medicine, University of Florida College of Medicine , Gainesville From the Masonic Medical Research Laboratory, Utica, NY (A.B., J.M.D., A.C.Z., C.A.), and CV Therapeutics Inc, Palo Alto, Calif (L.B.). InCarda Therapeutics, Newark, CA; and Gilead Sciences, Foster City, CA, USA Department of Clinical Research, Gilead Sciences, Inc., Foster City, CA 94404; InCarda Therapeutics Newark CA USA From the Saint Luke’s Mid America Heart Institute, Kansas City, MO (S.V.A., M.K., Y.L., P.G.J., J.A.S.); University of Missouri-Kansas City (S.V.A., M.K., J.A.S.); and Gilead Sciences, Foster City, CA (P.Y., L.B.). From the Departments of Medicine (J.C.S., S.S., L.B.) and Pharmacology (S.P.B., L.B.), University of Florida, Gainesville, Fla; University of Ferrara (P.G.B., B.C., G.S.), Ferrara, Italy; and Schering-Plough Research Institute (A.M., E.O.), San Raffaele Science Park, Milan, Italy. CV Therapeutics, Palo Alto, Calif, USA From the Department of Biology, Gilead Sciences, Inc, Palo Alto, CA. CV Therapeutics, Palo Alto, California 94304 Department of Cardiovascular Therapeutics, Gilead Sciences, Inc, Foster City, CA, USA From the Referral Center for Cardiomyopathies, Careggi University Hospital, Florence, Italy (I.O.); Gilead Sciences, Inc, Foster City, CA (J.L.H., R.F.-F., C.B., L.B.); Department of Preclinical and Clinical Pharmacology and Center of Molecular Medicine, University of Florence, Florence, Italy (R.C.); Veterans Affairs Palo Alto Health Care System and Stanford University, Palo Alto, CA (J.M.); and Hypertrophic Cardiomyopathy Center, Division of Cardiology, Tufts Medical Center, Boston, MA (M.S.M.). Gilead Sciences Incorporated, Fremont, CA, USA Former employee of Gilead Sciences, Inc.; Foster City California Department of Biological Sciences, Gilead Sciences, 333 Lakeside Drive, Foster City, CA 94404, USA From the Section of Cardiology, University of Illinois at Chicago and the Jesse Brown VA Medical Center, Chicago, IL (J.D.L., E.-M.J., H.A.L., H.L., L.G., P.K., N.P., S.C.D.); the Department of Physiology and Biophysics, University of Illinois at Chicago, Chicago, IL (M.M.M., B.G.P., D.M.T., R.J.S.); the Division of Cardiology, Emory University School of Medicine, Atlanta, GA (J.D.L., D.S.); and Gilead, Palo Alto, CA (D.Z., L.B.). From the Department of Cardiology and Pneumology (S.W., H.M.R., S.L.W., S.B., T. Sowa, T. Schulte, L.S.M.), Georg-August-University, Göttingen, Germany; Department of Cardiology, Angiology & Pneumology (J.B.), Ruprecht-Karls-University, Heidelberg, Germany; Gilead Sciences (L.B.), Palo Alto, CA; Department of Pharmacology (E.G., D.M.B.), University of California, Davis, CA; and Departments of Internal Medicine and Molecular Physiology and Biophysics (M.E.A.), University of Iowa Carver College of... Department of Clinical Research Gilead Sciences, Inc. Foster City CA USA Gilead Science, Inc. Foster City California CV Therapeutics, Palo Alto, California 94304, Departments of Medicine and Pharmacology, College of Medicine, University of Florida, Gainesville, Florida 32610, and University of Virginia School of Medicine, Charlottesville, Virginia 22908 From the Divisions of Cardiology (I.F., A.E.G.) and Clinical Pharmacology (S.R., I.B.), Departments of Medicine (I.F., A.E.G., S.R., I.B.) and Pharmacology (I.F., I.B.), Vanderbilt University, Nashville, Tenn; CV Therapeutics (D.Z., L.B.), Palo Alto, Calif; and the Department of Pharmacology (T.V.-Y.), University of Illinois, Chicago, Ill. Gilead Sciences Inc.Palo AltoCaliforniaUSA From the Division of Cardiology, Department of Medicine, University of Florida Health Sciences Center, Gainesville. InCarda Therapeutics, Inc, Newark, CA (D.S.E., L.B.). Department of Medicine, University of Florida, Gainesville (Y.S., L.W., J.C.S.), and CV Therapeutics, Palo Alto, Calif (L.B.). Department of Biology, Cardiovascular Therapeutic Area, Gilead Sciences, Fremont, CA 94555; InCarda Therapeutics, Newark, CA (L.B.). From the Masonic Medical Research Laboratory (S.S., A.B., C.A.), Utica, NY; and Gilead Sciences, Inc (L.B.), Palo Alto, Calif. From The Heart Institute (H.H., S.L.H., B.Z.S., R.A.K.), Good Samaritan Hospital, Los Angeles, Calif; Division of Cardiovascular Medicine (B.Z.S., R.A.K.), Keck School of Medicine, University of Southern California, Los Angeles, Calif; Section of Cardiac and Thoracic Surgery (J.M.A.), Good Samaritan Hospital, Los Angeles, Calif; Gilead (formerly Cardiovascular Therapeutics), Inc (L.B., A.K.D., J.C.S.), Palo Alto, Calif. From the Department of Preclinical and Clinical Pharmacology (R.C., M.D.L., F.S., L.S., S.S., E.C., A.M.), Department of Physiology (C.F., B.T., C.T., C.P.), and Center of Molecular Medicine (R.C., C.F., M.D.L., F.S., L.S., S.S., C.T., C.P., E.C., A.M.), University of Florence, Florence, Italy; Gilead Sciences Inc, Palo Alto, CA (L.Y., P.F., L.B.); Heart Science Center, Imperial College London, London, UK (M.Y.); and Referral Center for Cardiomyopathies, Careggi University Hospital, Florence, Italy ... Division of Cardiovascular Therapeutics, Gilead Sciences, Foster City, California. Department of Biology, Gilead Sciences, Fremont, California From the TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, and Harvard Medical School, Boston, Mass (B.M.S., D.A.M., S.A.M., C.M.H., C.H.M., E.B.); Chaim Sheba Medical Center, Tel Hashomer, Israel (H.H.); CV Therapeutics, Palo Alto, Calif (L.B.); Medisch Spectrum Twente, Enschede, The Netherlands (P.M.); HeartLung Centre, Nijmegen, The Netherlands (F.W.A.V.); and Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn (B.J.G.). From the TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, and Harvard Medical School, Boston, Mass (B.M.S., E.B., C.M.H., J.Q., D.A.M.); Gilead Science, Inc, Palo Alto, Calif (L.B., W.W., E.K.-P.); University Hospital Brno, Brno, Czech Republic (J.S.); and Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands (F.W.A.V.). From Beth Israel Deaconess Medical Center (T.N., C.A.M.T., J.R.M.P., R.L.V.) and Harvard Medical School (T.N., R.L.V.), Boston, MA; the Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland, and Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland (T.N.); University of São Paulo School of Medicine, São Paulo, Brazil (C.A.M.T., J.R.M.P.); and Gilead Palo Alto, Inc, Foster City, CA (L.B.). Department of Drug Research and Pharmacological Sciences, CV Therapeutics, Inc., Palo Alto, California; and Department of Medicine and Pharmacology, Vanderbilt University, Nashville, Tennessee From the Department of Clinical and Experimental Medicine, University of Ferrara (K.V., F.P., S.M., P.A.B.), and Schering-Plough Research Institute, San Raffaele Science Park, Milan (E.O.), Italy; and the Department of Medicine, Division of Cardiology, University of Florida, Gainesville (L.B.). From the Tel Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, Israel (E.C., A.H., D.Z., U.R., R.R., A.A., J.B., S.V.); Masonic Medical Research Laboratory, Utica, NY (D.H., C.A., H.B.-M.); Cardiovascular Research Program, Lankenau Institute for Medical Research, Wynnewood, PA (C.A.); and Gilead Sciences, Inc, Foster City, CA (L.B.). InCarda Therapeutics, Inc, Newark, CA (L.B.) From the Departments of Medicine (M.B.G., R.W.T., S.C., M.I.D., P.E.S., J.C.S., L.B.), Ophthalmology (M.B.G.), and Pharmacology and Therapeutics (M.J.O., J.C.S., L.B.), University of Florida, Gainesville, Fla, and Department of Medicine and Pharmacology (I.F., I.B.), Vanderbilt University, Nashville, Tenn. L.B.’s current address is Pharmacological Sciences, CV Therapeutics, Palo Alto, Calif. Department of Drug Research and Pharmacological Sciences, CV Therapeutics, Inc., Palo Alto, California Department of Biology, Gilead Sciences, Palo Alto, California Department of Biology, Gilead Sciences Inc., Foster City, California the Departments of Anesthesiology and Pharmacology (D.M.D., M.J.P.R., J.R.M.) and the Departments of Medicine and Pharmacology (L.B.), University of Florida, Gainesville. Gilead Sciences, Inc, Palo Alto, CA InCarda Therapeutics Inc, Newark, CA (P.M., L.B.). Gilead Sciences, Incorporated, Fremont, California CV Therapeutics Inc, Palo Alto, California Department of Biology Gilead Sciences Fremont CA USA From the Department of Medicine, University of Florida, Gainesville. Gilead Sciences, Inc, Foster City, CA. CV Therapeutics, Palo Alto, California Gilead Sciences, Palo Alto, California Gilead Sciences, Foster City, California Biology, Gilead Sciences Inc., 7601 Dumbarton Circle, Fremont, California 94555, United States the Departments of Medicine (L.B., J.C.S., J.R.), Pharmacology (L.B., D.M.D., S.P.B.), and Anesthesiology (D.M.D.), College of Medicine, University of Florida, Gainesville, and Schering-Plough Research Institute (A.M., S.D., E.O.), San Raffaele Science Park, Milan, Italy. Department of Cardiovascular Biology, Gilead Sciences, Fremont, California Department of Clinical Research, Gilead Sciences, Inc, Foster City, CA (L.B.). Department of Biology Cardiovascular Therapeutic Area Gilead Sciences Fremont CA USA InCarda Therapeutics, Newark, CA. Gilead Sciences, Foster City, CA (S.R., L.B.). Incarda Therapeutics, Inc Newark California Department of Biological Sciences, Gilead Sciences, Foster City, USA; InCarda Therapeutics Inc, 150 Northhill Drive, Brisbane, CA 94005, USA Cardiovascular Clinical Research, Gilead Sciences, Foster City, CA; Department of Biology, Cardiovascular Therapeutic Area, Gilead Sciences, Fremont, CA From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.). From the InCarda Therapeutics, Inc, Clinical Research and Development, Brisbane, CA (L.B.); Allen Institute for Cell Science, Seattle, WA (M.M.M.); and Faculties of Kinesiology and Medicine (W.R.G.), The University of Calgary, Alberta, Canada. From the Department NeuroFarBa (R.C., L.M., T.L., L. Santini, V.B., G.B., A.M., E.C.) and Department of Experimental and Clinical Medicine (C.F., F.G., J.M.P., C.T., C.P.), University of Florence, Italy; European Laboratory for Non-linear Spectroscopy (LENS), University of Florence & National Institute of Optics (INO–CNR), Sesto Fiorentino, Italy (C.C., L. Sacconi); Gilead Sciences Inc., Foster City, CA (L.B.); Department of Cellular and Molecular Medicine University of Arizona at Tucson, USA (J... From the Department of Biology, Cardiovascular Therapeutic Area, Gilead Sciences, Palo Alto, CA (L.W., H.L., J.C.S., L.B.); Cardio-Electrophysiological Research Laboratory, Wuhan University of Science and Technology, Wuhan, China (J.M., C.W., P.Z., A.L.); and Department of Pharmacology, University of California Davis, Davis (E.G., D.M.B.). InCarda Therapeutics Newark California Gilead Sciences, Inc., Palo Alto, California From the Departments of Pharmacology (D.W., L.B.) and Medicine (J.C.S., L.B.), University of Florida, Gainesville. InCarda Therapeutics, Inc, Newark, CA. From the Department of Clinical and Experimental Medicine, University of Ferrara (K.V., F.P., S.G., S.M., P.A.B.), and Schering-Plough Research Institute, Milan (E.O.), Italy; and Department of Medicine, Division of Cardiology, University of Florida, Gainesville (L.B.). Gilead Sciences, Inc Foster City, CA USA Gilead Sciences Fremont CA USA Department of Biology, Cardiovascular Therapeutic Area, Gilead Sciences, Inc., Fremont, CA From Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, University School of Medicine, New Haven, CT (Q.H., H.J.Z., H.Z., Y.H., F.J.G., W.M.); Center for Translational Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China (H.J.Z., W.M.); Gilead Sciences Inc, Foster City, CA (F.H.-K., P.F., L.Y., L.B., G.R.B.); and Department of Surgery, Yale University School of Medicine, New Haven, CT (G.T.). |
Incoming Links
Total number of triples: 367.